As consumer scrutiny of ultra-processed foods grows and category sales cool, the Swedish oatmilk brand leans on ...
And they received FDA support for Orphan Drug Designation and Fast Track Designation and they've got the opportunity to look at the IIb turning into a registration study, and that opens up the ...
Zacks Investment Research on MSN
BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential?
Beam Therapeutics BEAM and Intellia Therapeutics NTLA are clinical-stage companies developing investigational gene therapies.
Morning Overview on MSN
In the Pacific abyss, blue mud reveals life that breaks rules
Far below the reach of sunlight, scientists have stumbled on a patch of vivid blue mud on the Pacific seafloor that appears ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Researchers from CIIMAR and the University of Helsinki have discovered a new biochemical modification in natural ...
We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints that poorly understood prions may have been the vital missing ingredient ...
Women's hidden extra work, positive tipping points and new thinking on autism – there's much to chew on in this year's best ...
Fluorogenic DNA aptamers produce light only in the correct structural state, enabling programmable molecular logic, ...
With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results